Friday, March 29, 2024
California News Headlines


COVID Vaccinations For People With Compromised Immune Systems, Disabilities To Begin March 15

The state of California announced Friday that healthcare providers will be able to start vaccinating those with compromised immune systems and disabilities starting March 15.

By CBS Los Angeles , in Los Angeles , at February 12, 2021

original article published at https://losangeles.cbslocal.com/2021/02/12/covid-vaccinations-disabilities-compromised-immune-systems-march-15/

LOS ANGELES (CBSLA) — The state of California announced Friday that healthcare providers will be able to start vaccinating those with compromised immune systems and disabilities starting March 15.

Healthcare providers may use their clinical judgment to vaccinate individuals age 16-64 who are deemed to be at the very highest risk for morbidity and mortality from COVID-19 as a direct result of one or more of the following severe health conditions:

  • Cancer, current with debilitated or immunocompromised state
  •  Chronic kidney disease, stage 4 or above
  • Chronic pulmonary disease, oxygen-dependent
  •  Down syndrome
  • Immunocompromised state (weakened immune system) from solid organ
    transplant
  • Pregnancy
  • Sickle cell disease
  • Heart conditions, such as heart failure, coronary artery disease, or cardiomyopathies (excludes hypertension)
  • Severe obesity (Body Mass Index ≥ 40 kg/m2)
  • Type 2 diabetes mellitus with hemoglobin A1c level greater than 7.5%

If as a result of a developmental or other severe high-risk disability one or more of the following applies:

  •  The individual is likely to develop severe life-threatening illness or death from COVID-19 infection
  • Acquiring COVID-19 will limit the individual’s ability to receive ongoing care or services vital to their well-being and survival
  • Providing adequate and timely COVID care will be particularly challenging as a result of the individual’s disability

Currently, vaccines may be distributed to populations identified in Phase 1A and Phase 1B, Tier 1. and Phase 1B, Tier 1.

Comments